# Invitris — Creating new protein-based drugs at scale

```yaml
url: "https://forg.to/companies/invitris"
website: "https://invitris.com/"
industry: "Healthtech"
company_size: "1-10 employees"
headquarters: "Munich, Germany"
is_hiring: false
open_roles: 0
verified: false
created: 2026-07-23
```

## About Invitris

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

## Links

- Website: https://invitris.com/
- Forg: https://forg.to/companies/invitris

---
Listed on [Forg](https://forg.to) — the professional network for builders

_HTML version: https://forg.to/companies/invitris_